Executive Summary
One-paragraph overview of purpose, scope, and go/no-go decision criteria to orient reviewers and approvers.
A concise memo ensures consistent scope, traceable approvals, and measurable acceptance criteria, reducing rework and operational risk. For regulated environments, it also documents controls needed to satisfy statutes and standards, including the ESIGN Act (15 U.S.C. ch. 96) and state electronic transaction rules (UETA) when records or approvals are stored electronically.
The Business Testing Memo is prepared by testing leads and project managers and reviewed by cross-functional stakeholders before execution.
After review and sign-off, the memo becomes the authoritative reference for conducting tests and documenting results.
Oversees test design and execution, assigns test owners, and ensures traceability of test artifacts. Coordinates defect triage and approves final acceptance results before release or deployment.
Reviews the memo for regulatory coverage, documents audit evidence requirements, and confirms recordkeeping practices meet applicable statutes and industry rules.
One-paragraph overview of purpose, scope, and go/no-go decision criteria to orient reviewers and approvers.
Clear list of systems, modules, data sets, and test types included and explicitly excluded from this test cycle.
High-level test scenarios and objective pass/fail criteria, with references to detailed test scripts or automation suites.
Planned start/end dates, milestone checkpoints, and named owners responsible for execution and remediation.
Assessment of business and compliance risks if tests fail, plus contingency and rollback plans.
Required approvers, signature blocks, and list of artifacts to retain as audit evidence after testing.
| Field | Configuration |
|---|---|
| Approval Order | Sequential routing by role and email |
| Authentication | Email-link or SMS code per signer |
| Notifications | Auto-reminders at defined intervals |
| Evidence Capture | Attach audit trail and signed PDF to record |
Choose platforms that support secure signing, access controls, and audit trails to document approvals and preserve evidence.
Ensure the chosen provider supports your retention and compliance requirements, including any needed BAAs or advanced signer authentication.
At least 10 business days before testing begins
3–5 business days per reviewer
Specify exact start and end MM/DD/YYYY
Allow 5–10 business days for fixes
Before production deployment or release cutover
Memo draft shared with reviewers for comment.
Comments resolved and final draft prepared.
Required signatures collected and timestamped.
Signed memo and audit trail stored in repository.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | No | No | Yes, limited | Yes, limited |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| Envelope Cap | No cap | 100 envelopes/user/year | Varies | Varies | Varies |
Optica used a concise memo to align cross-functional owners on a platform upgrade scope and rollback plan.
A healthcare provider documented testing for a patient portal release using synthetic data and a BAA.